Livio Pagano

About Livio Pagano

Livio Pagano, With an exceptional h-index of 77 and a recent h-index of 50 (since 2020), a distinguished researcher at Università Cattolica del Sacro Cuore, specializes in the field of leucemie, infezioni, mieloma, aspergillosi, linfoma.

His recent articles reflect a diverse array of research interests and contributions to the field:

Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey

Laboratory and clinical management capacity for invasive fungal infections: the Italian landscape

The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey

CPX-351 exploits the gut microbiota to promote mucosal barrier function, colonization resistance and immune homeostasis

Survival in multiple myeloma and SARS‐COV‐2 infection through the COVID‐19 pandemic: Results from the EPICOVIDEHA registry

Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022

Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study

Second Neoplasms in Italian Patients with Hairy Cell Leukemia after Treatment with Cladribine: A Multicenter Investigation and Literature Review

Livio Pagano Information

University

Position

Professore Associato Ematologia

Citations(all)

27358

Citations(since 2020)

13845

Cited By

18221

hIndex(all)

77

hIndex(since 2020)

50

i10Index(all)

264

i10Index(since 2020)

155

Email

University Profile Page

Google Scholar

Livio Pagano Skills & Research Interests

leucemie

infezioni

mieloma

aspergillosi

linfoma

Top articles of Livio Pagano

Laboratory and clinical management capacity for invasive fungal infections: the Italian landscape

Infection

2024/2

The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey

Leukemia & lymphoma

2024/1/28

CPX-351 exploits the gut microbiota to promote mucosal barrier function, colonization resistance and immune homeostasis

Blood

2024/1/18

Survival in multiple myeloma and SARS‐COV‐2 infection through the COVID‐19 pandemic: Results from the EPICOVIDEHA registry

Hematological Oncology

2024/1

Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study

American Journal of Hematology

2024

Second Neoplasms in Italian Patients with Hairy Cell Leukemia after Treatment with Cladribine: A Multicenter Investigation and Literature Review

2024/4/11

Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management

Annals of Hematology

2023/11/29

NPM1-mutated myeloid neoplasm with low percentage of blasts.

American Journal of Hematology

2024/2/23

Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry

International Journal of Antimicrobial Agents

2023/10/1

Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 …

Leukemia

2023/9

Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry

Therapeutic advances in hematology

2023/3

Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry

Frontiers in immunology

2023/2/24

Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in “Real-Life”: The SEIFEM Experience

Cancers

2023/7/1

SARS-CoV-2 infection in patients with mastocytosis: an EPICOVIDEHA report

Journal of investigational allergology & clinical immunology

2023/6/15

Livio Pagano
Livio Pagano

H-Index: 45

SARS‐CoV‐2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID‐19 cohort

Hematological Oncology

2023/2

Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post–CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey

Blood Advances

2023/6/13

A review of prophylactic regimens to prevent invasive fungal infections in hematology patients undergoing chemotherapy or stem cell transplantation

2023/12/2

Livio Pagano
Livio Pagano

H-Index: 45

COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA)

Haematologica

2022/5

See List of Professors in Livio Pagano University(Università Cattolica del Sacro Cuore)